KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Revenue (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Revenue for 16 consecutive years, with $18.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 24.34% to $18.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $96.2 million, a 28.89% increase, with the full-year FY2025 number at $96.2 million, up 28.89% from a year prior.
  • Revenue was $18.8 million for Q4 2025 at Biolife Solutions, down from $28.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $40.7 million in Q3 2022 to a low of -$41.3 million in Q4 2022.
  • A 5-year average of $21.7 million and a median of $23.8 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 214.56% in 2021, then plummeted 210.6% in 2022.
  • Biolife Solutions' Revenue stood at $37.3 million in 2021, then tumbled by 210.6% to -$41.3 million in 2022, then soared by 66.13% to -$14.0 million in 2023, then surged by 208.1% to $15.1 million in 2024, then increased by 24.34% to $18.8 million in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Revenue are $18.8 million (Q4 2025), $28.1 million (Q3 2025), and $25.4 million (Q2 2025).